El Nasr Pharmaceutical Chemicals Co., commonly known as ADWIC, is an Egyptian pharmaceutical company located in Abu-Zaabal, a city in the Qalyubia Governorate. The company was founded in 1960 as a joint venture between the Egyptian government and the Czechoslovakian government. Today, ADWIC is a public company listed on the Egyptian Stock Exchange.
Contact Information
- Address: Abu-Zaabal, Qalyubia Governorate, Egypt .
- Phone: +20 2 4610100
- Fax: +20 2 4610060
- Email: [email protected]
- Website: www.adwic.com
Offices
ADWIC has offices in several locations throughout Egypt, including:
- Cairo: 22 Kamal El Din Salah Street, Downtown
- Alexandria: 51 El Horreya Road, Raml Station.
Customer service contact information for ADWIC :
- Phone: +20 122 340 2222
- Email: [email protected]
You can visit their website (www.adwic.com.eg) for more information on their products, services, and contact information.
Factories
- Abu-Zable, Cairo
- Tel. +2 02 44604411
- Tel. +2 02 44604500
Cairo Office
- Address : 28 Talaat Harb st.,Cairo
- Tel. 02 5746168
El Nasr Product Catalog.pdf – Download Link
ADWIC – Contact Information
Factories
- Address: Abu-Zaabal, Qalubia – Egypt – P.O Box: 491
- Tel. 44604500
- Tel. : 44604411
Web site: www.elnasrpharma.com - Email : [email protected]
- Email: [email protected]
Marketing Branches and Scientific Office
- Address: Abu-Zaabal, Cairo
- Tel. 44688860
- Tel. 44689995
Cairo Sales office
- Address: Gesr El-sweas St.
- Tel.: 26234763 -26237436
Alexandria sales office
- Address: 13 Mortada Basha St.
- Tel.: 035748578
Qwesna sales office
- Address: 7 Ebraheem El-Khaleel St.
- Tel.: 048 573927
Swohag sales office
- Address: 5 Gesr swohag St.
- Tel.: 093 2323268
Zakazeek Sales office
- Address: El-Hrar Houses St.
- Tel.: 055-2374548
Scientific Office
- Tel./ Fax: 25919913
- Address: 1 Jul. 26 St. Cairo
Cairo Office
- Tel. / Fax: 25746168
- Address: 28 Talaat Harb St. Cairo
El Nasr Product Catalog.pdf – Download Link
Statistics
As of December 31, 2021, ADWIC had a market capitalization of approximately EGP 2.6 billion (USD 165 million). The company reported total revenues of EGP 1.1 billion (USD 70 million) in 2020, with a net profit of EGP 152 million (USD 9.6 million).
News
In November 2021, ADWIC announced that it had signed a memorandum of understanding (MOU) with Saudi pharmaceutical company Tabuk Pharmaceuticals for the production and distribution of pharmaceutical products in Egypt and Saudi Arabia.
In August 2021, ADWIC announced that it had secured EGP 300 million (approximately USD 19 million) in funding from the Egyptian National Investment Bank to support the expansion of its pharmaceutical production facilities.
In June 2021, ADWIC signed an agreement with the Egyptian Ministry of Health and Population to supply a range of essential medicines to public hospitals and healthcare facilities throughout Egypt. The agreement was valued at EGP 180 million (approximately USD 11 million).
Board Members
ADWIC’s current board of directors includes:
- Dr. Mohamed Nageeb Mohamed Ahmed
- Eng. Ayman Salah El Din Abdel Fattah
- Eng. Ahmed Hassan Helal
- Dr. Hala Farouk El Etreby
- Dr. Mohamed Farid Saleh
- Mr. Hisham Abdel Moneim El Saeed
- Dr. Tamer Abdel Fattah Salem
Other Useful Information
ADWIC produces a wide range of pharmaceutical products, including antibiotics, analgesics, anti-inflammatory drugs, and cardiovascular medications. The company’s manufacturing facilities are equipped with state-of-the-art technology and comply with international quality standards. ADWIC has a strong commitment to research and development and invests heavily in this area. The company has also been recognized for its efforts in corporate social responsibility, particularly in the areas of health and education.
El Nasr Company is the largest and earliest company in the field of drugs & Chemicals in Africa and the middle east. It was established in 1960 in Abu-Zaabal desert far 30 km from Cairo.
El-Nasr pharmaceutical chemical company is consider as a one of a leader companies that serve the medical market in Egypt and most of the Arabian, African and European countries.
El-Nasr pharmaceutical chemical company was established in 1960 and production started by the end of 1963.
Since, 1963 El-Nasr pharmaceutical company continuous to extend its activities in the field of the people’s therapy with high standards of manufacture, high quality, high efficacy and absolute safety. So, it hold a unique position in the pharmaceutical industry.
El-Nasr pharmaceutical chemical company applies typically G.M.P regulations in all including factories.
El-Nasr company is a Research & Development based company in all fields of pharmaceutical Industry aiming for Human & Animal Health and welfare through adopting industrial strategy that is built on Quality.
ADWIC – Product List
*This list is under construction, may be not fully updated.
Reporting Side effects or other Problems related to ADWIC’S products
In Egypt, the regulatory authority responsible for pharmacovigilance is the Egyptian Drug Authority (EDA). The EDA is responsible for ensuring the safety, efficacy, and quality of pharmaceutical products, as well as monitoring and reporting adverse reactions or incidents related to these products.
If you experience any problems or adverse effects related to a product manufactured by El Nasr Pharmaceutical Chemicals Co. (ADWIC), you should report these issues to the EDA. You can do so by contacting the EDA’s Pharmacovigilance Department directly or by submitting an adverse event report through the EDA’s online reporting system.
The contact information for the EDA’s Pharmacovigilance Department is as follows:
- Phone: +202 2735 9119
- Email: [email protected]
You can also visit the EDA’s website (www.eda.mohealth.gov.eg) for additional information on pharmacovigilance and how to report adverse events or incidents related to pharmaceutical products in Egypt.
شركة النصر للكيماويات الدوائية – أدويك |
Contact Us: If you have any notes or feedback you need to reach us with, feel free contacting us any time via e-mail( [email protected]). Please contact us via email ([email protected]) or via contact us form, if the information on this page is incorrect, or if you have other information to update this page.
Dr. Ahmad Baker, PharmD
Senior Pharmacist & Health Educator
With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.
Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.